Phase 3 EVOKE-01 Study of Sacituzumab Govitecan vs Docetaxel in NSCLC After Prior Platinum and Checkpoint Inhibitors

N. Reinmuth, D. Reznick, S. Y. Liu,M. C. Garassino,N. Girard,F. De Marinis, S. F. Mekan, R. Patel, M. Ding, L. Paz-Ares

JOURNAL OF THORACIC ONCOLOGY（2022）

引用 1|浏览4

暂无评分

关键词

antibody-drug conjugate, immune checkpoint inhibitors, phase III clinical trial

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络